MOESM4 of A six-gene prognostic model predicts overall survival in bladder cancer patients

Figshare2019-09-05 更新2026-04-29 收录

数据链接：

https://figshare.com/articles/dataset/MOESM4_of_A_six-gene_prognostic_model_predicts_overall_survival_in_bladder_cancer_patients/9776720 数据链接链接失效反馈

官方服务：

资源简介：

Additional file 4: Table S4. Clinical signatures, mRNA types and mutational signatures of all patients.

创建时间：

2019-09-05

Table_1_Circulating Tumor DNA Analyses Predict Disease Recurrence in Non-Muscle-Invasive Bladder Cancer.xlsx

膀胱癌预后

肿瘤DNA检测

Circulating tumor DNA (ctDNA) can be a prognostic biomarker for non-muscle-invasive bladder cancer (NMIBC); however, targeted sequencing has not been performed to detect ctDNA in NMIBC. We applied tar

NIAID Data Ecosystem70

Phase Fase II examination of irinotecan, cetuximab and everolimus for patients resistente to chemoptherapy with metastatic colorectal cancer and KRAS mutation or with KRAS wildtype after progression on therapy with irinotecan og cetuximab – effect and biological markers.

结直肠癌靶向治疗

肿瘤生物标志物

Main objective: • Disease control as the sum of number of patients with CR, PR and SD. Primary endpoints: Disease control as sum of number of patients with CR, PR, and SD

NIAID Data Ecosystem20

DataSheet_1_A novel risk score model based on gamma-aminobutyric acid signature predicts the survival prognosis of patients with breast cancer.zip

癌症预后预测

肿瘤生物标志物

BackgroundGamma-aminobutyric acid (GABA) participates in the migration, differentiation, and proliferation of tumor cells. However, the GABA-related risk signature has never been investigated. Hence,

NIAID Data Ecosystem10

Postoperative Serum Levels of sCD26 for Surveillance in Colorectal Cancer Patients

结直肠癌复发

肿瘤生物标志物

One of the main aims of the follow-up after curative resection of colorectal cancer is the early detection and treatment of tumor recurrence. We previously demonstrated decreased preoperative soluble

Figshare2016-01-15 更新50

Patient characteristics (including Age at diagnosis, Binet stage, Rai stage, IgVH mutation status (um indicates unmutated, m mutated), genomic aberrations such as deletion 11q, deletion 13q14, deletion 17p, trisomy 12, ZAP70 status (pos indicates ZAP70 expression > 20%, neg indicates ZAP70 expression < 20%) (n.d. indicates not done, 1 indicates variable present, 0 indicates variable not present).

慢性淋巴细胞白血病

肿瘤生物标志物

NIAID Data Ecosystem20